Dr Steven Okoli
Consultant Haematologist Imperial College Healthcare NHS Trust
Dr Okoli is a Consultant Haematologist at Imperial College Healthcare NHS Trust and an Honorary Senior Clinical Lecturer at Imperial College. His PhD research focused on treatments for haemolytic anaemia, and he has since developed expertise in sickle cell disease, thalassaemia, and rare anaemias.
As the principal investigator for multiple clinical studies, he leads early-phase trials of novel therapies for sickle cell disease and thalassaemia and is the NIHR specialty lead for North London Research Delivery Network. Additionally, he leads the adult stem cell transplant programme for sickle cell disease at Imperial College NHS Trust.
Dr Okoli is a co-founder of the Imperial Sickle Cell Group and the director of the Sickle Cell Alliance, both committed to improving patient outcomes through collaborative clinical and academic research. He is also a regular contributor to the Imperial BSc Haematology course and serve as faculty for the internationally renowned Imperial College FRCPath course.
